End-stage renal disease (ESRD) patients with medically refractory secondary hyperparathyroidism Nutritional, Metabolic, Endocrine
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed with secondary or tertiary hyperparathyroidism 2. Dialysis-dependent due to end-stage renal disease (ESRD) 3. Underwent parathyroidectomy between January 2023 and December 2024 4. Underwent a primary parathyroidectomy (i.e., no previous parathyroid surgery) 5. Underwent removal of multiple parathyroid glands during the procedure
Exclusion criteria
Exclusion criteria: 1. Reoperation for recurrent hyperparathyroidism 2. Underwent concurrent surgical procedures 3. Had only one parathyroid gland removed during surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Operative time measured using surgical records documenting time from skin incision to completion of surgery as recorded in operative reports at the time of surgery 2. Intraoperative frozen section requirements measured using the number of frozen section pathology reports obtained during surgery at the time of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy and positive predictive value of preoperative CT imaging for parathyroid gland identification, measured using comparison of preoperative CT-identified parathyroid gland count with total parathyroid gland count in final pathological report, with true positive defined as: preoperative prediction of =4 glands AND final pathology report showing =4 glands AND postoperative day 1 iPTH concentration <300 pg/dl, at preoperative CT imaging and postoperative day 1 iPTH measurement | — |
Countries
Taiwan